Robert Tjin Tham Sjin

A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity.

J. Folkman, R. Satchi‐Fainaro, A. Birsner, 2005, Cancer research.

VRK1 Is a Synthetic–Lethal Target in VRK2-Deficient Glioblastoma

Alborz Bejnood, Ying-ping Chen, E. Wilker, 2022, Cancer research.

In Vitro and In Vivo Characterization of Irreversible Mutant-Selective EGFR Inhibitors That Are Wild-Type Sparing

Juswinder Singh, M. Nacht, M. Raponi, 2014, Molecular Cancer Therapeutics.

NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor

E. Giovannetti, G. Peters, R. Bernards, 2015, Oncotarget.

Linking Antibody Fc Domain to Endostatin Significantly Improves Endostatin Half-life and Efficacy

J. Folkman, S. Gillies, B. Ahmed, 2008, Clinical Cancer Research.

NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor

E. Giovannetti, G. Peters, R. Bernards, 2015, Oncotarget.